RHPN1-AS1

Across TCGA pan-cancer cohorts, RHPN1-AS1 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated RHPN1-AS1 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RHPN1-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RHPN1-AS1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and HNSC show a favorable association.

LIHC, LGG, and LAML are the cancer types where RHPN1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.346	0.629	<.001	80	view →
LGG	DFS	Median	All	0.318	0.479	<.001	54	view →
LAML	DFS	Tertile	All	0.324	0.666	<.001	44	view →
SKCM	OS	Median	II,III,IV	0.512	0.206	.001	30	view →
MESO	DFS	Tertile	II,III,IV	0.170	0.742	.006	30	view →
UVM	OS	Median	III,IV	0.296	1.000	.005	26	view →
UCEC	DFS	Quartile	All	0.597	0.845	<.001	18	view →
HNSC	DFS	Quartile	IV	0.739	0.503	.002	17	view →
ESCA	DFS	Quartile	III,IV	0.311	0.516	.016	12	view →
GBM	DFS	Median	All	0.395	0.175	<.001	12	view →
THCA	DFS	Quartile	IV	0.712	1.000	.014	12	view →
LUSC	DFS	Median	II,III,IV	0.851	0.627	.030	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

RHPN1-AS1–LIHC (OS)

Open the LIHC breakdown →